Get the latest Science News and Discoveries

Scripps Scientists Pioneer Vaccine To Combat Deadly “Zombie Drug” Xylazine

Chemical biologists at Scripps Research have developed a preliminary "proof-of-concept" vaccine, potentially paving the way for the first effective treatment for xylazine overdose in humans. Xylazine, a sedative and pain reliever approved by the FDA for animals, causes severe side effects in humans

None

Get the Android app